This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround StoryBy Mario Cazombo / March 22, 2026
Frankenstein’s Index Fund August 6, 2025 / Alternative Investments, Drivers of Value, Economics, General, Investment Topics, Performance Measurement & Evaluation
How GenAI-Powered Synthetic Data Is Reshaping Investment Workflows August 6, 2025 / Artificial Intelligence, Drivers of Value, Future States, General, Investment Topics, Philosophy
